Literature DB >> 9088427

Exoantigens from trypanosoma cruzi contain cruzipain.

A Gruppi1, F M Cerbán, E Vottero-Cima.   

Abstract

This paper shows that human antibodies specific for exoantigens of pI 4.5 (Eas 4.5), released by the blood forms of the parasite, obtained from chagasic patients sera by immunoabsorption react with cruzipain, the major cysteinyl proteinase of Trypanosoma cruzi. Sera from mice immunized with Eas 4.5 also recognize cruzipain. In addition, mouse antisera to cruzipain were reactive with Eas 4.5 as well as with total antigens excreted by culture-trypomastigotes. This reactivity was inhibited by cruzipain as revealed by enzyme-linked immunosorbent assay (ELISA). Furthermore, it was observed by immunoblot that the exoantigens recognized by mouse antisera to cruzipain have molecular weights between 50 and 60 kDa and human antibodies specific for Eas 4.5 recognize cruzipain with apparent molecular weight of 50 kDa. These findings suggest the presence of cruzipain in Eas and the subsequent release of this enzyme by the parasite.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088427     DOI: 10.1016/s0001-706x(96)00616-x

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  3 in total

1.  Phospholipases a in trypanosomatids.

Authors:  María Laura Belaunzarán; Estela María Lammel; Elvira Luisa Durante de Isola
Journal:  Enzyme Res       Date:  2011-04-05

Review 2.  Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease.

Authors:  Luíza Dantas-Pereira; Rubem Menna-Barreto; Joseli Lannes-Vieira
Journal:  Front Cell Dev Biol       Date:  2021-12-20

3.  Inhibition of HIV-1 replication in human monocyte-derived macrophages by parasite Trypanosoma cruzi.

Authors:  Guadalupe Andreani; Ana M Celentano; María E Solana; Silvia I Cazorla; Emilio L Malchiodi; Liliana A Martínez Peralta; Guillermina L Dolcini
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.